The circulation of H5N1 bird flu in animals and limited infections in humans have motivated flu preparedness activities, such as stockpiling vaccines. Social media posts have baselessly implied that these efforts are evidence that a new laboratory-derived version of the virus is going to cause a pandemic — or even that there is a conspiracy to release bird flu from a lab.
Stories by Kate Yandell
Third Night of the Democratic Convention
RFK Jr.’s Exaggerations on Chronic Disease in Children
Independent presidential candidate Robert F. Kennedy Jr. has given children’s health and the “chronic disease epidemic” a prominent role in his campaign. Diagnoses of a variety of chronic conditions in children have increased in recent decades, but likely not to the extent that Kennedy claims or for the reasons he gives.
Final Night of the GOP Convention
Night 3 of the Republican National Convention
Wind Energy’s Key Environmental Advantage? Low Emissions
Antarctic Ice Loss Is Significant, Contrary to Claims
Antarctica is losing ice mass to the ocean, contributing to global sea level rise. But a popular video misrepresented work focused on Antarctic ice shelves — which float in the sea at the edges of the continent — to incorrectly suggest that “it is unclear if Antarctica is losing any ice on balance.”
‘Who Is Bobby Kennedy?’ Video Promotes Debunked Anti-Vaccine Narratives
A recent video promoting independent presidential candidate Robert F. Kennedy Jr. promises to “start with some irrefutable facts.” The over 30-minute video, narrated by actor Woody Harrelson, begins with some biographical truths about the candidate, but veers into promoting various debunked or unsupported narratives about vaccines.
Q&A on H5N1 Bird Flu
Q&A on Reducing COVID-19 Risk for Elderly, Immunocompromised
While the risks associated with COVID-19 generally have decreased over time due to prior exposure to the vaccines and the virus, some people remain at elevated risk, such as the elderly and immunocompromised. The updated COVID-19 vaccines and, in some cases, a new monoclonal antibody can provide increased protection for this group.